What is the most likely diagnosis for a patient with axillary lymphadenopathy, marked leukocytosis, and a left shift on peripheral blood smear?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Differential Diagnosis: Acute Leukemia vs. Chronic Lymphocytic Leukemia vs. Infection/Reactive Process

The most likely diagnosis in a patient presenting with axillary lymphadenopathy, WBC 27,000/µL, and left shift on peripheral blood smear is an acute leukemia, though bacterial infection with reactive leukocytosis and chronic lymphocytic leukemia must be systematically excluded through immediate peripheral smear review and flow cytometry.

Immediate Diagnostic Approach

The presence of marked leukocytosis (27,000/µL) with a left shift demands urgent evaluation to distinguish between three primary diagnostic categories:

1. Acute Leukemia (Highest Priority to Exclude)

Peripheral blood smear review is the critical first step 1. Look specifically for:

  • Circulating blasts (immature cells with high nuclear-to-cytoplasm ratio, prominent nucleoli)
  • Blast percentage >20% suggests acute leukemia
  • Even lower blast counts with appropriate clinical context warrant bone marrow evaluation 2

If blasts are present or suspected:

  • Obtain bone marrow aspirate and biopsy immediately 1
  • Send for flow cytometry immunophenotyping to distinguish AML from ALL 1
  • Perform conventional cytogenetics (karyotype) plus FISH analysis 1
  • This is a medical emergency if blast count approaches hyperleukocytosis levels

Key clinical features favoring acute leukemia:

  • Constitutional symptoms (fever, weight loss, fatigue) 3
  • Bruising or bleeding (thrombocytopenia)
  • Anemia
  • Rapid symptom onset (days to weeks)
  • Patient appears ill 4

2. Chronic Lymphocytic Leukemia (CLL)

CLL can present with lymphadenopathy and leukocytosis, but has distinct features:

Diagnostic criteria for CLL 5, 6:

  • Absolute lymphocyte count ≥5,000/µL (this patient's 27,000 WBC likely includes significant lymphocytosis)
  • Mature-appearing small lymphocytes on smear (not left shift with immature forms)
  • Immunophenotype: CD5+, CD19+, CD20+ (low), CD23+, surface Ig low 5, 6

Critical distinction: CLL shows mature lymphocytes, NOT a left shift with bands and immature granulocytes. A true "left shift" (increased bands, metamyelocytes, myelocytes) argues strongly against CLL 7.

If lymphocytosis with mature cells:

  • Flow cytometry of peripheral blood is diagnostic (bone marrow not required) 8
  • CLL patients typically present less acutely than acute leukemia 4
  • Lymphocyte doubling time <6 months or >50% increase over 2 months suggests active disease 7

3. Reactive Leukocytosis from Bacterial Infection

Left shift is the hallmark of bacterial infection 4:

  • Increased bands, metamyelocytes, and myelocytes
  • Toxic granulations in neutrophils 3
  • WBC can double within hours with infection 3

However, isolated infection-related hyperleukocytosis (>100,000) is extremely rare 9. At WBC 27,000, infection remains possible but:

  • Search for infectious source (pneumonia, abscess, severe soft tissue infection)
  • Fever, elevated inflammatory markers (CRP, ESR)
  • Lymphadenopathy from infection is typically tender, mobile, and associated with local infection

Algorithmic Decision Tree

Step 1: Review peripheral blood smear immediately

  • Blasts present → Acute leukemia until proven otherwise → Bone marrow biopsy + flow cytometry + cytogenetics 1
  • Mature lymphocytes predominant → CLL likely → Flow cytometry on peripheral blood 8
  • Left shift with bands/immature granulocytes, no blasts → Infection likely → Search for infectious source, monitor CBC

Step 2: If smear shows left shift without clear blasts:

  • Assess clinical acuity: Is patient septic, febrile, with clear infection source?
    • Yes → Treat infection, repeat CBC in 24-48 hours
    • No → High suspicion for evolving acute leukemia → Proceed to bone marrow biopsy 2

Step 3: Flow cytometry results guide definitive diagnosis:

  • Myeloid blasts → AML
  • Lymphoid blasts → ALL
  • CD5+ mature B-cells → CLL
  • Non-diagnostic → Bone marrow biopsy mandatory 2

Critical Pitfalls to Avoid

  1. Do not assume infection without identifying a clear source 10, 3. Leukocytosis with lymphadenopathy and no obvious infection should trigger hematologic workup.

  2. Do not delay bone marrow biopsy if blasts are suspected 1, 2. Early flow cytometry may be non-diagnostic in evolving disease; tissue diagnosis is definitive.

  3. Do not confuse CLL lymphocytosis with left shift 7. CLL shows mature lymphocytes; left shift indicates granulocytic response (infection) or myeloid malignancy.

  4. WBC >100,000 is a medical emergency (leukostasis risk) regardless of cause 4. This patient at 27,000 is not yet at that threshold but requires urgent evaluation.

  5. Lymphadenopathy in CLL is typically generalized (multiple nodal regions), not isolated axillary 7. Isolated axillary adenopathy with leukocytosis raises concern for lymphoma or acute leukemia with extramedullary disease.

Most Likely Diagnosis Based on Presentation

Given axillary lymphadenopathy + WBC 27,000 + left shift, the combination suggests:

  • If left shift = immature granulocytes/blasts: Acute myeloid leukemia with extramedullary involvement
  • If left shift misinterpreted and actually lymphocytosis: CLL, though isolated axillary nodes are atypical
  • If true neutrophilic left shift with toxic changes: Severe bacterial infection (abscess, pneumonia)

The presence of a true left shift (bands, metamyelocytes) makes CLL unlikely 7. This narrows the diagnosis to acute leukemia versus infection. Immediate peripheral smear review for blasts is the decisive next step 1, 10.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.